UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Tension on the linker gates the ATP-dependent release of dynein from microtubules

Nature communications, 2014-08, Vol.5 (1), p.4587-4587, Article 4587

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

Clinical cancer research, 2021-04, Vol.27 (7), p.1882-1892

2021

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Study Evaluating ASTX727 (decitabine and cedazuridine) and Venetoclax Combination Therapy in Newly Diagnosed AML Patients Unfit for Intensive Induction Chemotherapy

Blood, 2021-11, Vol.138 (Supplement 1), p.1245-1245

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT108: A first-in-human, Phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT108-CT108

2021

Link zum Volltext

Verfügbarkeit prüfen

A first-in-human, phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9085-9085

2022

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Melphalan for Pediatric Patients Undergoing Hematopoietic Cell Transplantation

Journal of clinical pharmacology, 2022-07, Vol.62 (7), p.873-882

2022

Link zum Volltext

Verfügbarkeit prüfen

Determination of melphalan in human plasma by UPLC–UV method

Cancer chemotherapy and pharmacology, 2019-05, Vol.83 (5), p.905-910

2019

Link zum Volltext

Verfügbarkeit prüfen

The time is now: model-based dosing to optimize drug therapy

International journal of pharmacokinetics, 2017-11, Vol.2 (4), p.213-215

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract A072: Preliminary results of ASTX660, a novel non-peptidomimetic cIAP1/2 and XIAP antagonist, in 107 patients with solid tumors or lymphoma

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.A072-A072

2019

Link zum Volltext

Verfügbarkeit prüfen

Engineered Dynein Mutants Reveal Minimal Structural and Catalytic Requirements for Processive Motility

Biophysical journal, 2012-01, Vol.102 (3), p.38a-38a

2012

Link zum Volltext

Verfügbarkeit prüfen

A Force Dependent Gating Mechanism Inhibits ATP Dependent Release of Dynein from Microtubules

Biophysical journal, 2013-01, Vol.104 (2), p.383a-383a

2013

Link zum Volltext

Verfügbarkeit prüfen

Plasma and Intracellular Pharmacokinetic (PK) Analysis of Fludarabine in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S253-S253

2016

Link zum Volltext

Verfügbarkeit prüfen

565 - Improved Population Pharmacokinetic Model for Busulfan in Neonates and Children Facilitated by a Web-Based Bayesian Tool for Dosing and Therapeutic Drug Monitoring

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S395-S395

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved Population Pharmacokinetic Model for Busulfan in Neonates and Children Facilitated by a Web-Based Bayesian Tool for Dosing and Therapeutic Drug Monitoring

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S395-S395

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients

Biology of blood and marrow transplantation, 2017-10, Vol.23 (10), p.1701-1713

2017

Link zum Volltext

Verfügbarkeit prüfen

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

Journal of the American Heart Association, 2017-12, Vol.6 (12), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study

Journal of cardiovascular electrophysiology, 2019-05, Vol.30 (5), p.651-657

2019

Link zum Volltext

Verfügbarkeit prüfen

Probing High-order Protein Complexes Using Native Mass Spectrometry and Hydrogen/Deuterium Exchange Mass Spectrometry: A Case Study Using Fresh and Commercial Hemoglobin Samples

Journal of the American Society for Mass Spectrometry, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

A millimeter water-in-oil droplet as an alternative back exchange prevention strategy for hydrogen/deuterium exchange mass spectrometry of peptides/proteins

Analyst (London), 2024-04, Vol.149 (8), p.2388-2398

2024

Link zum Volltext

Verfügbarkeit prüfen

Use of group IIB metal ions as charge carriers for collision‐induced dissociation of glycopeptide and glycan

Rapid communications in mass spectrometry, 2023-01, Vol.37 (2), p.e9424-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

CaptiveSpray Differential Ion Mobility Spectrometry Device with Enhanced Ion Transmission and Improved Resolving Power

Journal of the American Society for Mass Spectrometry, 2023-05, Vol.34 (5), p.820-825

2023

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

The American journal of cardiology, 2016-10, Vol.118 (8), p.1258-1263

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient Outcomes From a Specialized Inherited Arrhythmia Clinic

Circulation. Arrhythmia and electrophysiology, 2016-01, Vol.9 (1), p.e003440-e003440

2016

Link zum Volltext

Verfügbarkeit prüfen

Interactive Segmentation for Diverse Gesture Types Without Context

2024 IEEE/CVF Winter Conference on Applications of Computer Vision (WACV), 2024, p.7173-7183

2024

Link zum Volltext
IEEE_Xplore

THE RELATIONSHIP BETWEEN THE QUANTITATIVE EXTENT OF MYOCARDIAL FIBROSIS AND BURDEN OF NON-SUSTAINED VENTRICULAR TACHYCARDIA IN HYPERTROPHIC CARDIOMYOPATHY: A DELAYED CONTRAST ENHANCED MRI STUDY

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1569-1569

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)
Tagungsberichte
(1)

Sprache

Englisch
(30)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tension on the linker gates the ATP-dependent release of dynein from microtubules

Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)

A Phase 1 Study Evaluating ASTX727 (decitabine and cedazuridine) and Venetoclax Combination Therapy in Newly Diagnosed AML Patients Unfit for Intensive Induction Chemotherapy

Abstract CT108: A first-in-human, Phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors

A first-in-human, phase 1 study of ASTX029, a dual-mechanism inhibitor of ERK1/2, in relapsed/refractory solid tumors

Population Pharmacokinetics of Melphalan for Pediatric Patients Undergoing Hematopoietic Cell Transplantation

Determination of melphalan in human plasma by UPLC–UV method

The time is now: model-based dosing to optimize drug therapy

Abstract A072: Preliminary results of ASTX660, a novel non-peptidomimetic cIAP1/2 and XIAP antagonist, in 107 patients with solid tumors or lymphoma

Engineered Dynein Mutants Reveal Minimal Structural and Catalytic Requirements for Processive Motility

A Force Dependent Gating Mechanism Inhibits ATP Dependent Release of Dynein from Microtubules

Plasma and Intracellular Pharmacokinetic (PK) Analysis of Fludarabine in Pediatric Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients

565 - Improved Population Pharmacokinetic Model for Busulfan in Neonates and Children Facilitated by a Web-Based Bayesian Tool for Dosing and Therapeutic Drug Monitoring

Improved Population Pharmacokinetic Model for Busulfan in Neonates and Children Facilitated by a Web-Based Bayesian Tool for Dosing and Therapeutic Drug Monitoring

Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review

The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study

Probing High-order Protein Complexes Using Native Mass Spectrometry and Hydrogen/Deuterium Exchange Mass Spectrometry: A Case Study Using Fresh and Commercial Hemoglobin Samples

A millimeter water-in-oil droplet as an alternative back exchange prevention strategy for hydrogen/deuterium exchange mass spectrometry of peptides/proteins

Use of group IIB metal ions as charge carriers for collision‐induced dissociation of glycopeptide and glycan

CaptiveSpray Differential Ion Mobility Spectrometry Device with Enhanced Ion Transmission and Improved Resolving Power

Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy

Patient Outcomes From a Specialized Inherited Arrhythmia Clinic

Interactive Segmentation for Diverse Gesture Types Without Context

THE RELATIONSHIP BETWEEN THE QUANTITATIVE EXTENT OF MYOCARDIAL FIBROSIS AND BURDEN OF NON-SUSTAINED VENTRICULAR TACHYCARDIA IN HYPERTROPHIC CARDIOMYOPATHY: A DELAYED CONTRAST ENHANCED MRI STUDY

Suchergebnisse filtern